Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doron Rimar

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Inflammation|April 23, 2013
Higher expression of latency-associated peptide on the surface of peripheral blood monocytes in patients with rheumatoid arthritis may be protective against articular erosionsGleb Slobodin, Lisa Kaly, Regina Peri, et al.
Case Reports in Infectious Diseases|September 23, 2016
Q Fever Risk in Patients Treated with Chronic Antitumor Necrosis Factor-Alpha TherapyJulianna Hirsch, Anna Astrahan, Majed Odeh, et al.
Rheumatology (Oxford, England)|January 24, 2018
Central retinal vein occlusion in temporal arteritis: red sign or red herring?Lisa Kaly, Gleb Slobodin, Doron Rimar, et al.
Rambam Maimonides Medical Journal|April 28, 2023
Giant Cell Arteritis: State of the Art in Diagnosis, Monitoring, and TreatmentAbid Awisat, Shiri Keret, Amal Silawy, et al.
Annals of the Rheumatic Diseases|September 10, 2020
Response to: 'Tofacitinib for the treatment of polyarteritis nodosa: a literature review'. Correspondence on 'Tofacitinib for polyarteritis nodosa: a tailored therapy' by Rimar <i>et al</i>Doron Rimar, Abid Awisat, Lisa Kaly, et al.
Clinical Rheumatology|November 13, 2019
Crowned dens syndrome, yet another rheumatic disease imposterAbid Awisat, Itzhak Rosner, Doron Rimar, et al.
Rheumatology International|April 22, 2015
Semaphorin 3A: an immunoregulator in systemic sclerosisDoron Rimar, Yuval Nov, Itzhak Rosner, et al.
The Israel Medical Association Journal : IMAJ|March 18, 2021
Acute Gout SacroiliitisLisa Kaly, Igor Bilder, Michael Rozenbaum, et al.
Seminars in Arthritis and Rheumatism|September 11, 2016
Autoinflammatory associated vasculitisShira Ginsberg, Itzhak Rosner, Michel Rozenbaum, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosisDoron Rimar, Itzhak Rosner, Yuval Nov, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Inflammation|April 23, 2013
Higher expression of latency-associated peptide on the surface of peripheral blood monocytes in patients with rheumatoid arthritis may be protective against articular erosionsGleb Slobodin, Lisa Kaly, Regina Peri, et al.
Case Reports in Infectious Diseases|September 23, 2016
Q Fever Risk in Patients Treated with Chronic Antitumor Necrosis Factor-Alpha TherapyJulianna Hirsch, Anna Astrahan, Majed Odeh, et al.
Rheumatology (Oxford, England)|January 24, 2018
Central retinal vein occlusion in temporal arteritis: red sign or red herring?Lisa Kaly, Gleb Slobodin, Doron Rimar, et al.
Rambam Maimonides Medical Journal|April 28, 2023
Giant Cell Arteritis: State of the Art in Diagnosis, Monitoring, and TreatmentAbid Awisat, Shiri Keret, Amal Silawy, et al.
Annals of the Rheumatic Diseases|September 10, 2020
Response to: 'Tofacitinib for the treatment of polyarteritis nodosa: a literature review'. Correspondence on 'Tofacitinib for polyarteritis nodosa: a tailored therapy' by Rimar <i>et al</i>Doron Rimar, Abid Awisat, Lisa Kaly, et al.
Clinical Rheumatology|November 13, 2019
Crowned dens syndrome, yet another rheumatic disease imposterAbid Awisat, Itzhak Rosner, Doron Rimar, et al.
Rheumatology International|April 22, 2015
Semaphorin 3A: an immunoregulator in systemic sclerosisDoron Rimar, Yuval Nov, Itzhak Rosner, et al.
The Israel Medical Association Journal : IMAJ|March 18, 2021
Acute Gout SacroiliitisLisa Kaly, Igor Bilder, Michael Rozenbaum, et al.
Seminars in Arthritis and Rheumatism|September 11, 2016
Autoinflammatory associated vasculitisShira Ginsberg, Itzhak Rosner, Michel Rozenbaum, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosisDoron Rimar, Itzhak Rosner, Yuval Nov, et al.
Pageof 10